REBECCA HOLT: Open Payments
NPI 1619696994 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,922 in 100 payments from 19 companies in 2025. Trend: 2023 $314 · 2024 $1,791 · 2025 $2,922
Food & beverage: $1,694Consulting: $1,140Education: $88
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $1,342 |
| ABBVIE INC. | 17 | $308 |
| Janssen Biotech, Inc. | 11 | $303 |
| Galderma Laboratories, L.P. | 26 | $177 |
| GENZYME CORPORATION | 7 | $146 |
| Incyte Corporation | 6 | $143 |
| Lilly USA, LLC | 4 | $88 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $67 |
| Organon LLC | 5 | $54 |
| Cipher Pharmaceuticals US LLC | 1 | $52 |
Products named: Bimzelx, TREMFYA, SKYRIZI, NEMLUVIO, DUPIXENT, OPZELURA, RINVOQ, EBGLYSS.
Industry payments across SC — which companies pay providers there.
